Pivmecillinam Hydrochloride Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 200 mg, 400 mg
Reference Brands: Selexid (EU)
Category:
Antibiotics
Pivmecillinam hydrochloride is available in Tablets
and strengths such as 200 mg, 400 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Pivmecillinam hydrochloride is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Pivmecillinam hydrochloride can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Pivmecillinam, also known as amdinocillin pivoxil, is an orally active prodrug of mecillinam, an extended-spectrum penicillin antibiotic. It is chemically the pivaloyloxymethyl ester of mecillinam, designed to enhance oral absorption and improve therapeutic effectiveness. Pivmecillinam is primarily used in the treatment of uncomplicated urinary tract infections (UTIs) and is especially effective against common uropathogens.
In the United States, pivmecillinam is indicated for the treatment of uncomplicated UTIs in adult women caused by susceptible isolates of Escherichia coli, Proteus mirabilis, and Staphylococcus saprophyticus. Its targeted antibacterial activity and favorable resistance profile make it a valuable option for first-line UTI management in many regions.
Pivmecillinam is marketed under brand names such as Selexid and Pivya and is widely used across Europe and other global markets. As a beta-lactam antibiotic, it works by inhibiting bacterial cell wall synthesis, leading to bacterial cell death. Its oral administration, proven efficacy, and safety profile support its continued use in the management of uncomplicated urinary tract infections.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing